Straws are discrete research notes that relate to a particular aspect of the company. Grouped under #hashtags, they are ranked by votes.
A good Straw offers a clear and concise perspective on the company and its prospects.
Please visit the forums tab for general discussion.
Technically, the shares have responded well after a slow start since the FY earnings report.
They are sitting at/near new 52w highs, and above a well known area of resistance up to $14 which has been a barrier a few times looking back 12-18 months.
There is further overhead resistance at several points up to the all-time high above $20, but assuming the company delivers on its targets, it should get above those levels eventually.
Contracts delayed, my heart's in doubt,
But if they win, I'll dance and shout.
My faith's on the line, but still I do cling,
Hoping Objective makes shareholders sing.
Update 22/08/2024
FY24 NPAT of $31m
Given the change in accounting policy, NPAT will always look higher than previous and hence it should trade on a lower multiple than before. The current share price of just above $13 on an EPS of $0.329 indicates a PE of around 40x. I feel that this is not an outrageous valuation considering a comparable company in Technology One trades on over 50x PE.
I'm going to assume 15% CAGR NPAT growth for the next 5 years and applying a terminal PE of 35x. Discounted back 10% pa gives me a valuation of $13.55.
Disc: Held IRL and on Strawman.
Update 04/09/2023
OCL had flagged earlier this year that growth would be subdued. NPAT came in at $21.1m which was only just above FY22 NPAT of $21m.
I believe that growth will return in FY24 and beyond and if they can compound at 15% for the next 5 years then at a terminal PE of 45x, I calculate a valuation of $11.85 to achieve a 10% pa return.
One thing to keep in mind is that OCL is changing accounting policy. Only 50% of R&D will now be expensed compared to 100% in the past.
I think I will likely value OCL on a free cash flow basis in order for consistency. Free cash flow for FY23 was pretty similar to NPAT at around $20m. Going to leave this figure here as a comparison for next period as NPAT is going to jump up based on the new accounting policy. Under the new policy NPAT would have come in around $32m.
Disc: Not held.
Update 25/11/22
OCL released a trading update for FY23 flagging decreased revenue growth and profit margin reduction. This is as a result of a transition from perpetual licencing to subscription based revenue for their products. There will also be salary growth and more spending to win new customers.
Revenue growth is expected to be single digit rather than double digit as seen in the past for the next FY but expected to reaccelerate again in FY24 as subscription revenue is recognised.
I have updated my valuation to $11.38 assuming decreased profit growth to single digit and reaccelerating from FY24 onwards.
I had recently sold out of OCL in my real life portfolio (was planning on selling on SM too but accidentally placed a buy order instead) but will look to buy back in with the expected weakness following this update.
Disc: Not held IRL, held on SM
Update 14/07/2022
OCL released a trading update for their FY22 results
NPAT for FY22 of $21m (which doesn't include a $1.4m settlement with NZCC). So actual NPAT of around $19.6m.
This is still around a 20% increase to NPAT YOY.
Will maintain my current valuation as I think it is still a bit too expensive at the current share price.
Disc: Not held IRL or on Strawman
Update 13/01/2022
OCL released a trading update detailing their unaudited 1HY2022 results.
NPAT: $9.8m which is up 35% compared to 1HY2021
I'll assume FY2022 NPAT of around $20m which would represent around 20% increase compared to FY2021 of $16.1m.
So if they can maintain 20% EPS growth for 5 years and trade on a PE of around 45x. To get a 10% return I have a target buy price of around $12.31.
Disc: Not held IRL or on Strawman
Original Report
Objective Corp is a software company which provides software for many government agencies.
When valuing stocks it is hard to predict what type of growth will occur in the future and so I prefer to think more in the line of: What price would I pay today that would allow a reasonable rate of return over the next 3-5 years.
At the current price, OCL is trading at a PE of around 114x and so if you buy at today's price you'd have to expect 25% EPS growth for the next 5 years and for OCL to be trading at a PE of 60x in FY26 in order to achieve around 10% return per year.
Personally I find this to be a bit rich for me so applying a 15% EPS growth for 5 years and a PE of 45x in FY26 gives me a valuation of $9.95.
However with these high quality, highly scalable companies which can maintain high levels of growth long term it would not be unreasonable for someone with a high risk tolerance to justify the current price but I would prefer to be a bit more conservative given current market conditions.
Objective Corporation released their FY24 results this morning. From their presentation:
Overall a solid result headlined by a very strong cash flow compared to FY23. On my numbers FCF came in around $37.5m compared to $20m in FY23.
Remember that OCL changed their accounting policy to only expense 50% of R&D in the P&L which makes the comparison of NPAT between the 2 periods a bit misleading. However, on a like for like basis, I have NPAT using the old method of accounting of around $27.2m which is still 29% higher than FY23 ($21.1m).
In his letter to shareholders, CEO Tony Walls indicated that although they did not quite reach their targets of 15% growth in ARR, they were also more efficient in deployment of their services which in term lead to a decrease in costs. They attributed this miss to a softening in economic conditions in NZ. They do think that going forward, a 15% growth in ARR is the target.
Disc: Held IRL and on Strawman.
I have written a new article about Objective Corp and buyback history.
https://www.growthgauge.com.au/p/is-objective-corporation-asxocl-a
Objective Corp reported last week. From their presentation:
Remember that OCL changed accounting policies in terms of expensing R&D. Changing from expensing 100% to 50%.
In 1H FY24, total R&D spend for $13.557m with $7.2m being expensed through the P&L. On a comparative basis, NPBT would have been around $13.3m compared to $10.7m in 1H FY23 had the R&D expense been expensed in the period. NPAT would be around flat only due to an increased tax expense in the current period.
Personally I thought this result was pretty good although I think it will be better to wait until the full year results for a better comparison given the seasonality of OCL's customers (public sector customers usually pay during the 2H).
In the shareholder letter from CEO Tony Walls, the outlook provided was strong with management targeting ARR growth of 15%. They also provided an update in regards to potential acquisitions with them having done some due diligence on a few potential candidates but ultimately deciding to focus on building the business organically.
Disc: Held IRL and on Strawman.
Objective release its FY23 result this morning. As guided to market the result will be muted compare to other years.
Revenue:
Customer Receipts
Operating Cash
No. Of Shares on issues
Objective corp is no doubt a very high-quality company with a very aligned CEO who owns a significant portion of the business. Historically, Objective corp has bought back its Shares on market at a very opportune time and they are currently going through a buyback program that intends to buy 10% of outstanding shares on market. Does that mean management thinks business isn't valued appropriately by the market?
So I have analyzed OCL's FY2013 to FY2022 results and put some of my FY2023 and FY2024expected figures to see
Objective Revenue and Free CF graph tells how the company has performed and what my expectation for the next 2 years.
Let's see how market sentiment has shifted for this company.
Now, Even for my projection revenue and Net profit for FY23 and FY24, I give Price/Sales = 8 and PE = 40 valuation comes in between $9.13 and $11.32 ( Not sure if the market will give this valuation in the future - but OCL is a very high-quality company run by high-quality management with recurring revenue serviced to very defensive customers and expensing 100% of R&D (~20% of Revenue) deserve premium )
So I am a bit baffled that Objective is buying back its share in the range of ~$12.00 - $12.80. It will be interesting to see how the next couple of years unfold and will give us insight as to how to value such a company.
PS: I has similar thought when $PME were buying back their shares at ~$25 in 2019. look at it today - even in a bear market, it returned 100%.
Objective CEO's recent letter has an interesting comment about the market.
Objective announced that they are expecting slowdown in revenue growth and margin compression for fy23 and i am not sure if this is going to be the story of FY23 for the most companies.. but it does look increasingly that way or this is probably because of Objective's strategic direction of offloading implementation to partners instead of inhouse for scale.?
Objective is very high quality company with very aligned founder in Tony. Although it is trading on very high multiple for single digit growth but again they are expensing 100% of their R&D.
Short term pain ahead for long term gain? May be one to watch out and dust off valuation for potential opportunity ?
Sold out completely. I’m concerned that government procurement has slowed down across all IT since COVID due to distractions. IT is focused on working from home desktop rather that digital transformation projects. I’ll watch from the sidelines for the next few reporting cycles
ASX Announcement for significant contract win for their RegTech business (formerly Itree Pty Limited). Looks like the Itree acquisition is working out. I understand NZ Police have significant contracts with PEGA Systems and ServiceNow so the fact that they chose a new vendor for this project is interesting especially with such a high profile project in Firearms in NZ in the wake of 2019 shootings. Note that the ARR for this contract has already been reported at 1HY2022.
Objective selected for firearms legislative reform
Objective RegWorks, a specialist end-to-end regulatory platform, has been selected by New Zealand Police to develop the firearms registry Sydney, Australia – Following a competitive multi-phase tender process, Objective Corporation (ASX:OCL) has been awarded a 5 year, circa $13M NZD contract for the implementation of the Arms Information System.
Objective RegWorks will be used by Police to manage the end-to-end regulation of registration and licensing for firearms as part of a programme that includes the establishment of a new Arms Information System (AIS) to support the effective regulation of New Zealand’s licensed firearms community (approximately 250,000 licence holders). The Arms Information System will be a secure digital platform that will manage the information related to arms (firearms, parts, ammunition and other restricted weapons), firearms licensing, and any activities associated with the possession and use of firearms. It will ultimately give Police a clear picture of all firearms transactions in New Zealand, and over time, all the legally owned firearms in New Zealand.
Ben Hobby, Global Vice President, RegTech at Objective said “Our team is deeply aware of the significant outcome this project will generate, which directly aligns with our company mission to drive stronger communities and nations with outstanding digital government software. The harrowing events of 2019 suddenly brought in to focus the need for reform and for an Arms Information System that will assist to underpin continuing freedoms that the people of Aotearoa have enjoyed for generations. We are extremely proud to be partnered with New Zealand Police to make this vision a reality.”
Objective and New Zealand Police have established a delivery partnership and are actively working on developing delivery phases now. This contract was recognised in Objective Corporation’s ARR result reported at 1HY2022, corresponding with the contract start date during that period. Under the terms of the contract, Objective agreed not to disclose the specific customer details at that time.
-ends-
Forgot to do a Straw for the results which came out a few weeks ago and saw no one else had done one either.
Another solid HY result for OCL. Results from their presentation below:
NPAT came in slightly above what they guided for in January but this was excluding $1.4m which they had to pay as part of a NZCC Settlement so reported NPAT was around 8.6m which is only a 20% increase compared to PCP.
I am willing to maintain my valuation from January of $12.30 as I believe this is a high quality company that is still growing its top and bottom line at good rates however the current price is still a bit rich for me so am waiting patiently for a good entry point.
Disc: Not held
@techbunny - Was a Seveneves reference there?
Twas I ignored for being a bunny?
The multiple now, 'tis very funny.
The buyers might have been some funds
But the founder hasn't yet sold one.
So I'll hold it for the yolo ark
Right or wrong; it'll be a lark.
Objective Is Mostly Owned By Its Founder,
For $1.7b this one has low float.
The high valuation makes some investors flounder
But index huggers are all in the same boat!
They'll have to buy shares whatever the price
For long term holders, that should be nice.
One of the best unknown tech stocks on the ASX, Objective Corp is again on track to deliver another year of solid growth.
(I held years ago, and never got back in due to a stupid anchoring bias!!)
The company has reported preliminary results for FY21:
CEO Tony Wallis said he expected a "material lift in revenue and profitability" in FY22.
You can read the ASX announcement here
At >100x earnings, my only problem with OCL is the price. That being said, with a high cash balance, fast growth, high quality cash flows and fully expensed development costs, that mulitple could fairly be normalised lower.
Congrats to all long term investors. Shares are up >10x in the last 5 years, and the company has returned 17% of the cost base in dividends (excluding franking credits!)
Objective Corporation (ASX:OCL) provides the following trading update for the first half of financial year 2021 (1HY2021), based on unaudited management accounts as at December 31, 2020.
The expected headline results for 1HY2021 are a revenue increase of 40% to $46.5m (1HY2020: $33.3m) with an EBITDA increase of 74% to $11.8m (1HY2020: $6.8m).
Annual Recurring Revenue (ARR) at 31 December 2020 was $70.1m, representing an increase of 30% over 31 December 2019 ($54.1m). Perpetual right to use (upfront licence) fees continued to decline as a percentage of revenue, representing only 3.6% of total revenues in 1HY2021 (7.4% in 1HY2020).
Cash balance at 31 December 2020 was $27.7m. During 1HY2021, Objective paid $18.4m as consideration for the acquisition of Itree Pty Limited and fully franked dividends of $6.6m.
Objective Corp has acquired Australian 'RegTech' business iTree for $18.5m, or about 1.3x FY21 sales. It's customers include the Dept. of Home Affairs, Queensland Rail and Worksafe Tasmania.
iTrees products will be integrated into Objective's Content Solutions suite, and Objective will market these solutions to a wider market opportunity.
Objective has a great track record of making sensible bolt-on acquisitions, and this appears no different.
iTree is profitable and like Objective fully expenses R&D costs. The acquisition will be cashflow positive, EPS accretive and will be funded from existing cash reserves.
ASX announcement here
20-Dec-2019: CCZ Equities Research: Objective Corp (OCL): No Objections to ARR growth and expanded margins
Excerpts:
---------------------------
Disclosure: I don't hold OCL shares currently, but they're on my watchlist.
Objective Corp. has reduced its share count by a massive 32% since 2008, starting with the company aggressively repurchasing 11% of shares outstanding during the GFC.
Those that didn’t sell into the buy-back have seen their stake in the company — and their share of the profits — increase by about 47% over the past 9 years. So while profits have grown 310% in the period, per share profits have climbed 500%.
It did this all while being essentially debt free, and making numerous bolt-on acquisitions -- something that it's capital light nature greatly enables.
Incredibly shareholder friendly and prudent capital management